SCHEMBL3258747

SCHEMBL3258747

COc1ccc(C(=O)NCCNc2cc(NCCNC(C)=O)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 6/20 0.57
MTNR1A P48039 3/20 0.54
MTNR1B P49286 3/20 0.54
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2D6 P10635 1/20 0.54
TSHR P16473 1/20 0.54
CYP2C19 P33261 1/20 0.54
CLK4 Q9HAZ1 1/20 0.54
KMT2A Q03164 3/20 0.51
MEN1 O00255 1/20 0.51
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
ALDH1A1 P00352 1/20 0.49
NFKB1 P19838 1/20 0.49
NFKB2 Q00653 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163394 0.90 ADORA1 (0.51) ADORA3MTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL3170716 0.89 MAPT (0.53) ADORA3CLK4KMT2AMEN1NPC1
SCHEMBL3168663 0.89 ADORA1 (0.48) ADORA3CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3165176 0.88 POLB (0.57) ADORA3CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3162824 0.88 ADORA1 (0.47) ADORA3CYP1A2CYP3A4CYP2D6TSHR
SCHEMBL3171511 0.88 ADORA3 (0.51) ADORA3MTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL3166238 0.86 ALDH1A1 (0.54) ADORA3MTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL3161933 0.86 CYP1A2 (0.58) ADORA3MTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL3168745 0.86 ADORA2A (0.56) ADORA3MTNR1AMTNR1BCYP1A2CYP3A4
SCHEMBL3155352 0.86 ALDH1A1 (0.47) ADORA3CYP1A2CYP3A4CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed